Trial reportJMIR formative research2025
Virtual Reality Interventions of Daily Versus Weekly Data Collection in Patient-Reported Outcomes Among Adults With Cancer: Pilot Survey Study.
Trial report in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Virtual reality (VR) interventions are increasingly used in health care settings to improve patient-reported outcomes (PROs). PROs are commonly evaluated at weekly intervals with data collected via digital surveys. While weekly assessments have benefits, VR devices enable more frequent in-device data collection. It remains unclear whether PROs collected more frequently provide more information on these interventions than PROs collected more infrequently. Objective: This pilot study explored differences between daily and weekly PRO data collection in a VR intervention with nature imagery, with and without guided imagery, among patients with cancer. Methods: Patients with cancer (n=8) were randomly assigned to one of four intervention groups: (1) virtual reality-assisted guided imagery (VRAGI), (2) VR without guided imagery, (3) desktop VR with guided imagery, or (4) desktop VR without guided imagery. Devices were mailed to participants' homes for 15-20 minutes of daily use over 3 weeks. Weekly outcomes (pain, anxiety, depression, and well-being) were assessed using items from the Edmonton Symptom Assessment Scale. Daily outcomes were captured via in-device pre-post surveys. Data were analyzed descriptively, using visual trend comparisons to explore patterns. Results: Of 41 patients who consented, 8 provided complete and usable data. Weekly outcomes showed no consistent trends. In contrast, daily data revealed more nuanced patterns, such as early symptom relief, plateaus, and "double-bottom" effects. The addition of guided imagery did not consistently enhance outcomes beyond VR alone, although the VRAGI condition showed the greatest improvement in well-being. Given the small sample size, these findings should be considered exploratory. Conclusions: This pilot study suggests that daily PRO data might offer richer insight into intervention effects than weekly assessments. Further research with larger samples is needed to confirm these patterns.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.